Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials

Overview of attention for article published in Frontiers in oncology, December 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 25,917 followers.

RT @FrontOncology: New research: Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials: Tyr…

21 Dec 2023

Reply Repost Favourite

New research: Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials: Tyrosine Kinase Inhibitors (TKIs) is revolutionizing the management of pediatric Chronic Myeloid Leukemia (CML), offering… https://t.co/fAo

20 Dec 2023

Reply Repost Favourite

RT @DrFateenata: The published version of our narrative review is now online ✔️ @FrontiersIn oncology. Tyrosine Kinase Inhibitors in pediat…

20 Dec 2023

Reply Repost Favourite

RT @DrFateenata: The published version of our narrative review is now online ✔️ @FrontiersIn oncology. Tyrosine Kinase Inhibitors in pediat…

20 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.